Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Overview of Exosomes01:36

Overview of Exosomes

3.2K
Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
3.2K
Tumor Immunotherapy01:27

Tumor Immunotherapy

850
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
850

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

N4-acetylcytidine modification bridges metabolic reprogramming and immune evasion in cancer: mechanisms and therapeutic implications.

Frontiers in immunology·2026
Same author

Navigating the Redox Precipice: Metabolic Gatekeeping as a Therapeutic Window in Pancreatic Precancer.

Frontiers in bioscience (Landmark edition)·2026
Same author

The tumor-nerve-immune electrical axis: A hypothesis-generating framework for electrochemical communication in cancer.

Biochimica et biophysica acta. Molecular basis of disease·2026
Same author

The mechano-immunological landscape in the tumor microenvironment: From mechanical sensing to a new therapeutic paradigm.

Materials today. Bio·2026
Same author

The astrocytic connectome: Gap-Junction topology beyond diffuse syncytium.

Trends in cell biology·2026
Same author

Targeting the Calcineurin Homologous Protein 1 (CHP1)-Transmembrane Protein 87A (TMEM87A) mechanosensing complex: a druggable vulnerability in metastatic ovarian cancer.

Molecular biomedicine·2026

Related Experiment Video

Updated: Nov 15, 2025

Preparation of Exosomes for siRNA Delivery to Cancer Cells
09:59

Preparation of Exosomes for siRNA Delivery to Cancer Cells

Published on: December 5, 2018

25.7K

Exosomes: Powerful weapon for cancer nano-immunoengineering.

Ya-Nan Pi1, Bai-Rong Xia2, Ming-Zhu Jin3

  • 1Department of Gynecology, Harbin Medical University Cancer Hospital, Harbin 150086, PR China.

Biochemical Pharmacology
|March 1, 2021
PubMed
Summary

Cancer nanomedicine using engineered exosomes shows promise for cancer immunotherapy (CIT). These nanomaterials can overcome the immunosuppressive tumor microenvironment, enhancing anti-tumor immune responses and potentially improving treatment efficacy.

Keywords:
Engineering exosomes (iExosomes)ExosomesImmunotherapyNanomedicineTumor microenvironment

More Related Videos

Using Nanoplasmon-Enhanced Scattering and Low-Magnification Microscope Imaging to Quantify Tumor-Derived Exosomes
09:30

Using Nanoplasmon-Enhanced Scattering and Low-Magnification Microscope Imaging to Quantify Tumor-Derived Exosomes

Published on: May 24, 2019

7.6K
In Vivo Immunogenicity Screening of Tumor-Derived Extracellular Vesicles by Flow Cytometry of Splenic T Cells
08:02

In Vivo Immunogenicity Screening of Tumor-Derived Extracellular Vesicles by Flow Cytometry of Splenic T Cells

Published on: September 23, 2021

2.8K

Related Experiment Videos

Last Updated: Nov 15, 2025

Preparation of Exosomes for siRNA Delivery to Cancer Cells
09:59

Preparation of Exosomes for siRNA Delivery to Cancer Cells

Published on: December 5, 2018

25.7K
Using Nanoplasmon-Enhanced Scattering and Low-Magnification Microscope Imaging to Quantify Tumor-Derived Exosomes
09:30

Using Nanoplasmon-Enhanced Scattering and Low-Magnification Microscope Imaging to Quantify Tumor-Derived Exosomes

Published on: May 24, 2019

7.6K
In Vivo Immunogenicity Screening of Tumor-Derived Extracellular Vesicles by Flow Cytometry of Splenic T Cells
08:02

In Vivo Immunogenicity Screening of Tumor-Derived Extracellular Vesicles by Flow Cytometry of Splenic T Cells

Published on: September 23, 2021

2.8K

Area of Science:

  • Oncology
  • Immunology
  • Nanomedicine

Background:

  • Cancer immunotherapy (CIT) faces challenges due to the complex immunosuppressive tumor microenvironment.
  • Exosomes, natural nanomaterials involved in intercellular communication, significantly influence immune responses and immunotherapy effectiveness.
  • Exosomal PD-L1 is implicated in promoting cancer progression and immunotherapy resistance.

Purpose of the Study:

  • To review the role of exosomes within the tumor immune microenvironment.
  • To highlight the application of engineered exosomes as a therapeutic strategy for cancer immunotherapy.
  • To discuss the clinical challenges and future prospects of exosome-based cancer therapies.

Main Methods:

  • Review of current literature on exosomes, tumor immune microenvironment, and cancer immunotherapy.
  • Analysis of exosome engineering strategies for therapeutic applications.
  • Discussion of clinical translation hurdles and future research directions.

Main Results:

  • Exosomes play a critical role in mediating intercellular communication within the tumor microenvironment.
  • Engineered exosomes can be utilized as nanomedicine to enhance cancer immunotherapy.
  • Exosomes possess inherent properties like bioavailability, stability, and targeting specificity suitable for therapeutic development.

Conclusions:

  • Engineered exosomes represent a promising adjuvant strategy for cancer immunotherapy.
  • Exosome-based nanomedicine can potentially overcome tumor immunosuppression and activate anti-tumor immunity.
  • Further research and clinical studies are needed to fully realize the therapeutic potential of exosomes in cancer treatment.